Peptide Network:Peptides Looksmaxxing·Maxxing Peptides·Peptide Scientists
#1
Clav's Stack
>98%
HPLC Verified
Every Order
COA Included
24+
Products
$200+
Free Shipping
Always
3rd-Party Tested
Back to Products
Triple-Agonist GLP-1 / GIP / Glucagon
Retatrutide

Triple-Agonist GLP-1 / GIP / Glucagon

Buy Retatrutide

Not For Human Use, Lab Use Only.

Triple incretin/glucagon receptor pharmacology—listed here as a research-grade lyophilized SKU with supplier-stated purity.

Select size

$134.99In Stock
Buy Retatrutide 10mg

≥98% Purity

HPLC Verified

Research Grade

Lyophilized

Fast Shipping

Free $200+

Specifications

CAS Number2381089-83-2
MechanismGLP-1 + GIP + Glucagon receptor agonist
Molecular Weight~5,766 Da
Storage−20°C (lyophilized) · 4°C in solution up to 4 weeks
Purity≥98% HPLC verified
FormLyophilized powder

Retatrutide — Mechanism of Action

M1

GLP-1 Receptor Agonism — Appetite & Insulin

Retatrutide activates GLP-1 receptors in the hypothalamus, reducing appetite and caloric intake. It also potentiates glucose-dependent insulin secretion and suppresses glucagon — the same pathway exploited by semaglutide, but as one component of a three-part mechanism.

M2

GIP Receptor Agonism — Adipose & Insulin Sensitization

GIP receptor signaling is discussed in incretin pharmacology as influencing adipose and beta-cell biology alongside GLP-1. Mechanistic reviews are the right place for pathway detail; this page does not summarize comparative human weight-change outcomes.

M3

Glucagon Receptor Agonism — Energy Expenditure

The glucagon receptor arm differentiates retatrutide from dual incretin designs in receptor coverage. Hepatic glucagon signaling is linked in the literature to glucose and lipid turnover; we do not quote human energy-balance or weight-loss deltas on this storefront.

M4

Liver Signaling (Preclinical / Literature)

Published work discusses glucagon and GLP-1 family signaling in hepatic lipid handling; specific magnitudes and human outcome claims belong in primary literature, not on this catalog page.

Retatrutide — Important Notice

This page summarizes identity, purity, and handling context for catalog navigation. It is not medical advice, a drug label, or a summary of clinical outcomes for any use. Materials are sold for legitimate laboratory research only; verify requirements with your institution and the supplier.

Buying Retatrutide: Concentration Reference

Figures below are volumetric / handling notes for lyophilized material only. They are not therapeutic dosing, efficacy claims, or instructions for use in humans or animals.

Protocol
Dose
Frequency
Notes
Subcutaneous Injection
2–12 mg/week
Once weekly
Illustrative weekly ranges sometimes discussed in scientific literature for this drug class—laboratory handling only; not a human protocol.
Low-Dose Entry
0.5–2 mg/week
Once weekly
Lower illustrated weekly ranges appear in some publications for titration discussions—reference only.
Compound note

Retatrutide — Reconstitution Notes

10mg vial + 2mL BAC water = 5mg/mL (5,000 mcg/mL). Example draws: 0.8mL = 4mg; 1.6mL = 8mg—solution math only.

Retatrutide is a lipidated GLP-3 analog — allow 2–5 min of gentle swirling for full dissolution. Post-reconstitution stable at 2–8°C for 4 weeks.

Retatrutide — Pair This With

BPC-157

BPC-157 is commonly discussed in tissue-repair literature alongside metabolic research programs; pairing rationale here is descriptive, not an outcome claim.

GHK-Cu

GHK-Cu is widely studied in dermal remodeling literature; many buyers keep it in the same cart for unrelated skin-research workflows.

TB-500

TB-500 (thymosin beta-4 fragment) appears in connective-tissue repair literature as a separate research line from incretin pharmacology.

Retatrutide

from $134.99

Shop Now